Every day, the sun rises on Wall Street, and a plethora of professional analysts wake to issue new opinions on stocks. Here at the Fool, we use our "This Just In" column to examine some of these picks -- and the track records of the firms behind them -- so individuals can make better investing decisions.
In addition to following professional banks, anyone can use Motley Fool CAPS to monitor the collective opinions of more than 135,000 members, many of whom demonstrate better investing insight than published analysts do.
More top-performing CAPS members are giving the thumbs up to Varian Medical Systems
Tightened capital budgets have hindered hospitals' ability to make big purchases. That pain has trickled down to medical device makers such as Intuitive Surgical
Varian has felt the same pressure for its advanced radiation therapy and X-ray equipment, but the company still managed to post positive sales growth in its most recent quarter. Many CAPS members believe pent-up demand will later be a big benefit to Varian, which commands more than half of the global cancer radiation equipment market. It currently generates about half of its revenue from abroad, but only 15% from Asia, and looks to increase that foreign component, with plans for strong growth in emerging markets such as China.
Varian's new Rapid Arc radiation system has been well-received, giving stiff competition to rivals TomoTherapy and Accuray
To see what the very best CAPS analysts are saying now about Varian Medical Systems -- as well as other winning stocks they're picking -- head on over to CAPS and have a look.
More Foolishness: